HomeBlogAplenty Icon PublicationInjectable anti-obesity drugs shown to benefit heart health

Injectable anti-obesity drugs shown to benefit heart health

by

Nov 24, 2024

Aplenty Icon Publication

Injectable weight loss drugs can improve heart health

A collection of studies presented at a recent American Heart Association (AHA) conference has confirmed the heart health benefits provided by the new anti-obesity drugs, semaglutide and tirzepatide, and how lifestyle interventions for weight loss affect heart biomarkers in diabetics.

Continue Reading

Category: Heart Disease, Illnesses and conditions, Body & Mind

Tags: GLP-1, Obesity, Cardiovascular, American Heart Association

Will We Get More Answers About UFOs in a Second Trump Term?

Nov 24, 2024

Aplenty Icon Publication

Illustration: Hulton Archive/GraphicaArtis/ Getty Images At first glance, the story of the U.S. government grappling with evidence of unidentified flying objects has cooled off since last year, when a whistleblower claimed (without firsthand evidence) that the Pentagon had alien bodies and otherworldly spacecraft in its possession. But the past few weeks have seen a number...

Previous

The Sleep Gap: Why Women Rest Less and Wake More

Nov 24, 2024

Aplenty Icon Publication

A new study highlights significant sleep differences between male and female animals, suggesting biological factors are more influential than lifestyle in determining sleep patterns. The findings prompt a reassessment of past biomedical research, which often excluded females, leading to possible misinterpretations in drug development and treatment effectiveness. Gender Differences in Sleep Patterns Females tend to...

Next

Further reading

Ozempic: A new hope for opioid and alcohol addiction treatment

Dec 26, 2024

Aplenty Icon Publication

The prevalence of substance use disorders, such as opioid and alcohol use disorders, has created a significant public health crisis. In the United States, drug overdose deaths surged from 18,000 in 1999 to over 107,000 in 2021. Alarmingly, opioids contributed to 75% of these fatalities. Similarly, alcohol use disorder affects...

Read More

A young bodybuilder’s tragic end highlights the dangers of performance-enhancing substances

Dec 26, 2024

Aplenty Icon Publication

A 21-year-old bodybuilder consumed a dangerous chemical known as 2,4-dinitrophenol (2,4-DNP) over several months, leading to his untimely death from multi-organ failure. His chronic use of the substance, combined with anabolic steroids, underscored a preoccupation with physical appearance and suggested a psychiatric condition called muscle dysmorphia. This case study, published...

Read More

More black holes discovered than expected in the early universe

Dec 26, 2024

Aplenty Icon Publication

Black holes are among the most mysterious and influential phenomena in the cosmos. They hold the key to understanding the early universe, galaxy formation, and the evolution of cosmic structures. Recent findings, published in The Astrophysical Journal Letters, driven by innovative imaging techniques, offer a groundbreaking perspective on how these...

Read More

Optimized by Optimole